US 7354900
Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides
granted A61KA61K38/1709A61P
Quick answer
US patent 7354900 (Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides) held by The Board of Regents of the University of Oklahoma expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/1709, A61P, A61P27/02, A61P31/04